Vertex Pharma (VRTX) volatility elevated at 58

Vertex Pharma (Nasdaq: VRTX) is recently down 39c to $37.08 after Piper Jaffray reiterated its Overweight rating and $56 price target. February and July call option implied volatility of 57 is above its 26-week average of 50 according to Track Data, suggesting larger price movement.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Novavax (NVAX) 11K contracts of August 28 weekly 9 calls trade, share price up 8.8%
• TeraWulf (WULF) August 10 calls, September 12 puts, October 9 puts active
• Teucrium Corn Fund (CORN) August 18, August 19 and September 19 calls active